LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
55.53 USD
0.78%
Market Closed
Updated:
Apr 28, 2024
LivaNova PLC
Research & Development
|
LivaNova PLC
Research & Development Peer Comparison
Comparables:
SN
LMDX
EKF
AGL
CREO
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Research & Development
-$193.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Research & Development
-$299m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Research & Development
-$131.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Angle PLC
LSE:AGL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Research & Development?
Research & Development
-193.8m
USD
-193.8m
USD
Based on the financial report for Dec 31, 2023, LivaNova PLC's Research & Development amounts to -193.8m USD.
What is LivaNova PLC's Research & Development growth rate?
Research & Development CAGR 5Y
-6%
-6%
Over the last year, the Research & Development growth was -24%. The average annual Research & Development growth rates for LivaNova PLC have been -7% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
